MGNX News
Archived Headlines
- US IPO Recap: Twitter starts countdown to November offering, Potbelly pops 10/07/13
- 7 US IPOs planned for the week of Oct 7 10/07/13
- Cancer biotech MacroGenics sets terms for $60 million IPO 10/01/13
- US IPO Recap: Benefitfocus, six others set terms as calendar rebuilds 09/08/13
- Cancer biotech MacroGenics files for a $60 million IPO 09/04/13
Cancer biotech Ignyta sets terms for $40 million IPO
Ignyta, a clinical-stage biotech developing targeted cancer therapeutics, announced terms for its IPO on Friday. The San Diego, CA-based company plans to raise $40 million by offering 4.4 million shares at $9.10. At that price, Ignyta would command a fully...read more
US IPO Recap: Antero completes $1.6 billion IPO, 13 companies file
There were seven US IPOs last week, including two by small health care companies that traded up more than 30%. Antero Resources (AR) raised $1.6 billion in the largest E&P IPO in a decade, just two days after midstream energy company Plains GP Holdings, LP...read more
MacroGenics prices IPO at $16, the high end of the original range
MacroGenics, which is developing targeted therapeutics for cancer and autoimmune diseases, raised $80 million by offering 5 million shares at $16, as anticipated in the revised terms announced Wednesday morning. The company had originally aimed to sell 4 million...read more
MacroGenics increases shares offered and raises price to $16, the high end of the range
MacroGenics, which is developing targeted therapeutics for cancer and autoimmune diseases, raised the proposed deal size for its upcoming IPO on Wednesday. The Rockville, MD-based company now plans to raise $80 million by offering 5.0 million shares at $16 per...read more